Distribution of 1298A > C polymorphism of methylenetetrahydrofolate reductase gene in patients with bipolar disorder and schizophrenia

European Psychiatry

Volumn 22, Issue 1, 2007, Pages 39-43

  Kempisty, Bartosz ^a   Bober, Anna ^a   Łuczak, Marta ^a   Czerski, Piotr ^a   Szczepankiewicz, Aleksandra ^a   Hauser, Joanna ^a   Jagodziński, Paweł P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Bipolar disorder I (BDI); Methylenetetrahydrofolate reductase (MTHFR); Polymorphism; Schizophrenia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CARBON; FOLIC ACID; METHYL GROUP;

ADULT; AGED; ARTICLE; BIPOLAR I DISORDER; CONTROLLED STUDY; FEMALE; FOLATE METABOLISM; GENE FREQUENCY; GENE LOCUS; GENE TRANSFER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HOMOZYGOTE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; STRATIFICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIPOLAR DISORDER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; ODDS RATIO; POLAND; POLYMORPHISM, GENETIC; RISK FACTORS; SCHIZOPHRENIA; SEX FACTORS;

EID: 33846551159     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2006.11.003     Document Type: Article

References (46)

1. Andreoli V.M., and Maffei F. Blood-levels of S-adenosylmethionine in schizophrenia. Lancet 2 (1975) 922
2. Anguelova M., Benkelfat C., and Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol Psychiatry 7 (2003) 646-653
3. Arinami T., Yamada N., Yamakawa-Kobayashi K., Hamaguchi H., and Toru M. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet 74 (1997) 526-528
4. Badner J.A., and Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7 (2002) 405-411
5. Bakker R.C., and Brandjes D.P. Hyperhomocysteinaemia and associated disease. Pharm World Sci 3 (1997) 126-132
6. Bottiglieri T., Godfrey P., Flynn T., Carney M.W., Toone B.K., and Reynolds E.H. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 53 (1990) 1096-1098
7. Cardno A.G., Marshall E.J., Coid B., Macdonald A.M., Ribchester T.R., Davies N.J., et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 56 (1999) 162-168
8. Carlsson A., and Linquist M. Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and norepinephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 20 (1963) 140
9. Craddock N., Dave S., and Greening J. Association studies of bipolar disorder. Bipolar Disord 6 (2001) 284-298
10. Craddock N., and Owen M. Chromosomal aberrations and bipolar affective disorder. Br J Psychiatry 164 (1994) 507-512
11. Creveling C.R. The role of catechol-O-methyltransferase in the inactivation of catecholestrogen. Cell Mol Neurobiol 23 (2003) 289-291
12. Crow T.J. Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 137 (1980) 383
13. Curtis D., Kalsi G., Brynjolfsson J., McInnis M., O'Neill J., Smyth C., et al. Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23-q24, and suggests the presence of additional loci on 1p and 1q. Psychiatr Genet 13 (2003) 77-84
14. DeLisi L.E., Mesen A., Rodriguez C., Bertheau A., LaPrade B., Llach M., et al. Genome-wide scan for linkage to schizophrenia in a Spanish-origin cohort from Costa Rica. Am J Med Genet 114 (2002) 497-508
15. Ewald H., Flint T., Kruse T.A., and Mors O. A genome-wide scan shows significant linkage between bipolar disorder and chromosome 12q24.3 and suggestive linkage to chromosome 1p22-21, 4p16, 6q14-22, 10q26 and 16p13.3. Mol Psychiatry 7 (2002) 734-744
16. First M.B., Spitzer R.L., Gibbon M., and Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV) (1996), American Psychiatric Press, Inc, Washington, D.C
17. Freeman J.M., Finkelstein J.D., and Mudd S.H. Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity. N Engl J Med 292 (1975) 491-496
18. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
19. Godfrey P.S., Toone B.K., Carney M.W., Flynn T.G., Bottiglieri T., Laundy M., et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336 (1990) 392-395
20. Han D.H., Kee B.S., Min K.J., Lee Y.S., Na C., Park D.B., et al. Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients. Neuroreport 17 (2006) 195-199
21. Kempisty B., Mostowska A., Gorska I., Luczak M., Czerski P., Szczepankiewicz A., et al. Association of 677C > T polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene with bipolar disorder and schizophrenia. Neurosci Lett 400 (2006) 267-271
22. Kirov G., O'Donovan M.C., and Owen M.J. Finding schizophrenia genes. J Clin Invest 115 (2005) 1440-1448
23. Kohn Y., Danilovich E., Filon D., Oppenheim A., Karni O., Kanyas K., et al. Linkage disequlibrium in the DTNBP1 (dysbindin) gene region and on chromosome 1p36 among psychotic patients from a genetic isolate in Israel: findings from identity by descent haplotype sharing analysis. Am J Med Genet B Neuropsychiatr Genet 128 (2004) 65-70
24. Kunugi H., Fukuda R., Hattori M., Kato T., Tatsumi M., Sakai T., et al. C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol Psychiatry 3 (1998) 435-437
25. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 73 (2003) 34-38
26. Maier W., Hofgen B., Zobel A., and Rietschel M. Genetic models of schizophrenia and bipolar disorder. Eur Arch Psychiatry Clin Neurosci 255 (2005) 159-166
27. Mamdani F., Jaitovich-Groisman I., Alda M., and Turecki G. Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications. Curr Psychiatry Rep 5 (2003) 484-492
28. Matsushita S., Muramatsu T., Arai H., Matsui T., and Higuchi S. The frequency of the methylenetetrahydrofolate reductase-gene mutation varies with age in the normal population. Am J Hum Genet 61 (1997) 1459-1460
29. Michelon L., and Vallada H. Genetics of bipolar disorder. Rev Bras Psiquiatr Suppl 3 (2004) 12-16
30. Muntjewerff J.W., Kahn R.S., Blom H.J., and den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry (Sep 20 2005) [Epub ahead of print]
31. Murray R.M., Sham P., Van Os J., Zanelli J., Cannon M., and McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 71 (2004) 405-416
32. Ohnishi T., Hashimoto R., Mori T., Nemoto K., Moriguchi Y., Iida H., et al. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 129 (2006) 399-410
33. Olney J.W. Role of excitotoxins in developmental neuropathology. APMIS Suppl 40 (1993) 103-112
34. Pasquier F., Lebert F., Petit H., Zittoun J., and Marquet J. Methylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult. J Neurol Neurosurg Psychiatry 57 (1994) 765-766
35. Regland B. Schizophrenia and single-carbon metabolism. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1124-1132
36. Regland B., Johansson B.V., and Gottfries C.G. Homocysteinemia and schizophrenia as a case of methylation deficiency. J Neural Transm Gen Sect 98 (1994) 143-152
37. Reif A., Pfuhlmann B., and Lesch K.P. Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Prog Neuropsychopharmacol Biol Psychiatry 7 (2005) 1162-1168
38. Sazci A., Ergul E., Kucukali I., Kara I., and Kaya G. Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: association is significant in men but not in women. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1113-1123
39. Shifman S., Bronstein M., Sternfeld M., Pisante A., Weizman A., Reznik I., et al. COMT: a common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 128 (2004) 61-64
40. Swann A.C., Geller B., Post R.M., Altshuler L., Chang K.D., Delbello M.P., et al. Practical clues to early recognition of bipolar disorder: a primary care approach, prim care companion. J Clin Psychiatry 7 (2005) 15-21
41. Tan E.C., Chong S.A., Lim L.C., Chan A.O., Teo Y.Y., Tan C.H., et al. Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. Psychiatr Genet 14 (2004) 227-231
42. Van der Put N.M., Gabreels J., Stevens F., Smeitink E.M.B., Trijbels J.A.M., Eskes F.J.M., et al. A second mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 62 (1998) 1044-1051
43. Vilella E., Virgos C., Murphy M., Martorell L., Valero J., Simo J.M., et al. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia. Prog Neuropsychopharmacol Biol Psych 29 (2005) 1169-1174
44. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44 (1987) 660-669
45. Zintzaras E. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr Genet 6 (2006) 105-115
46. Zintzaras E., and Ioannidis J.P. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 28 (2005) 123-137